Visual perception and macular integrity in non-classical CLN2 disease

Зрительное восприятие и целостность макулы при неклассическом течении заболевания CLN2
Eva Wibbeler, Christoph Schwering, Martin S. Spitzer, Angela Schulz, Simon Dulz, Miriam Nickel, Yevgeniya Atiskova, Jan Wildner
2022-06-02

cerliponase alfanon-classical CLN2 diseaseoptical coherence tomographyretinal degenerationvisual function
PURPOSE: Patients with CLN2 suffer from epileptic seizures, rapid psychomotor decline and vision loss in early childhood. The aim of the study was to provide longitudinal ophthalmic data of patients with confirmed genetic mutation and non-classical disease course, marked by later onset, protracted progression and prolonged life span. METHODS: Prospective, observational study to assess visual acuity, retinal features (Weil Cornell Ophthalmic Score), central retinal thickness (CRT) measured by optical coherence tomography and general disease progression (Hamburg CLN2 motor language score) in non-classical CLN2 patients. RESULTS: All patients received intracerebroventricular enzyme replacement therapy with cerliponase alfa. Mean age at last follow-up was 12.4 years; mean follow-up time 2.6 years. All cases demonstrated a stable Hamburg motor language CLN2 Score and Weill Cornell LINCL Ophthalmic Severity Score. Visual function remained stable in 4/6 patients, 2/6 patients showed a decrease, 4/6 cases had a stable CRT and 2/6 showed a reduction of CRT. One patient showed a massive macular thinning and low vision. A correlation with a specific mutation or age could not be verified. DISCUSSION: The presented longitudinal study characterizes the variable ocular involvement in non-classical CLN2 disease and contributes to the natural history description. The functional and morphologic data outline the necessity of regular ophthalmic examination. Ocular phenotyping and description of retinal degeneration in non-classical CLN2 disease.
1
All patients received intracerebroventricular cerliponase alfa, and mean follow-up was 2.6 years with a mean age of 12.4 years at final assessment.
2
Hamburg motor-language scores and Weill Cornell ophthalmic severity scores remained stable in all patients during follow-up.
3
One patient developed massive macular thinning and low vision, with no confirmed correlation between ocular findings and specific mutation or age.
4
The variable ocular involvement supports regular ophthalmic examinations and systematic retinal phenotyping in non-classical CLN2 disease.
5
This longitudinal study characterized visual function, retinal morphology, and disease progression in genetically confirmed patients with non-classical CLN2 disease.
6
Visual function remained stable in 4 of 6 patients, while 2 of 6 experienced decline; central retinal thickness was stable in 4 and reduced in 2.

Non-classical CLN2 disease in patients with confirmed genetic mutations

Longitudinal visual function and macular/retinal integrity, including visual acuity, retinal severity, and central retinal thickness, during disease progression

Publication Details
Publication Date
2022-06-02
Journal
Publisher
ISSN
Cited by
1
Access Type
Author Information
Authors
Eva Wibbeler
Christoph Schwering
Martin S. Spitzer
Angela Schulz
Simon Dulz
Miriam Nickel
Yevgeniya Atiskova
Jan Wildner
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%